Jane Street Group, LLC Galmed Pharmaceuticals Ltd. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.4 - $0.9 $5,613 - $12,630	-14,034 Reduced 51.55%	13,189 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.29 - $0.59 $3,862 - $7,858	13,319 Added 95.79%	27,223 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.35 - $0.65 $4,866 - $9,037	13,904 New	13,904 $4,000
Q3 2018 Nov 14, 2018	SELL	$10.55 - $15.28 $252,218 - $365,298	-23,907 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$5.04 - $17.96 $120,491 - $429,369	23,907 New	23,907 $284,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.02M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.